Found: 14
Select item for more details and to access through your institution.
Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 713, doi. 10.1111/apt.17107
- By:
- Publication type:
- Article
Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma.
- Published in:
- Internal Medicine, 2022, v. 61, n. 21, p. 3157, doi. 10.2169/internalmedicine.9237-21
- By:
- Publication type:
- Article
Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis.
- Published in:
- Hepatology Research, 2020, v. 50, n. 2, p. 174, doi. 10.1111/hepr.13437
- By:
- Publication type:
- Article
Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study.
- Published in:
- Hepatology Research, 2019, v. 49, n. 6, p. 617, doi. 10.1111/hepr.13328
- By:
- Publication type:
- Article
Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis.
- Published in:
- Hepatology Research, 2017, v. 47, n. 3, p. E120, doi. 10.1111/hepr.12738
- By:
- Publication type:
- Article
Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2602, doi. 10.3390/cancers12092602
- By:
- Publication type:
- Article
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B.
- Published in:
- Liver International, 2020, v. 40, n. 7, p. 1578, doi. 10.1111/liv.14482
- By:
- Publication type:
- Article
Long‐term hepatic function of patients with compensated cirrhosis following successful direct‐acting antiviral treatment for hepatitis C virus infection.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 2, p. 371, doi. 10.1111/jgh.15703
- By:
- Publication type:
- Article
Long‐term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct‐acting antivirals.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 1, p. 190, doi. 10.1111/jgh.15659
- By:
- Publication type:
- Article
Pruritus in Chronic Liver Disease: A Questionnaire Survey on 216 Patients.
- Published in:
- Acta Dermato-Venereologica, 2019, v. 99, n. 2, p. 220, doi. 10.2340/00015555-3064
- By:
- Publication type:
- Article
NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection.
- Published in:
- Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 12, p. 1759, doi. 10.1111/jgh.13016
- By:
- Publication type:
- Article
Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C.
- Published in:
- Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 8, p. 1309, doi. 10.1111/jgh.12945
- By:
- Publication type:
- Article